- 2014.12.26
Bringing patent infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the fifth report)
- 2014.12.09
Notice Regarding Market Purchase of the Company’s Own Shares and Completion of Acquisition
- 2014.11.05
Notice Regarding Purchase of the Company's Own Shares
- 2014.11.05
Notice of Revision of Forecast
- 2014.10.09
Notice of launch of the FCeM®Series, a new three-dimensional culture for cancer cells
- 2014.09.24
Change of Research Organization
- 2014.07.29
Notice of Revision of Forecasts
- 2014.07.22
Development of room temperature gelling stretchable hydrogel AQUAJOINT
- 2014.06.18
Revision of Consolidated Financial Results for the Fiscal Year Ended March 31, 2014 (From April 1, 2013 to March 31, 2014)
- 2014.06.05
Japan Chemical Industry Association RC Grand Prix Award Received -The 8th Annual Responsible Care Award-
- 2014.06.02
Bringing patent infringement actions in the United States concerning drug applications of generic drugs of “LIVALO®,” a therapeutic agent for hypercholesterolemia
- 2014.05.27
Marketing License of Bravecto, Veterinary Medical Product in the USA
- 2014.05.15
Notice of Resolution on Dividend Payment
- 2014.04.30
Discontinuation of the license agreement for a new therapeutic agent for thrombocytopenia
- 2014.04.25
A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production
- 2014.03.13
Notice Regarding Cancellation of Treasury Shares
- 2014.03.12
Notice Regarding Market Purchase of the Company’s Own Shares and Completion of Acquisition
- 2014.03.05
Bringing patent infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the fourth report)
- 2014.02.18
Sales of Fluralaner, active substance of Veterinary Medical Product
- 2014.02.18
Notice on Partial Amendment to the Articles of Incorporation
- 2014.02.18
Introduction of the Executive Officer System and Changes of Directors
- 2014.02.14
Notice regarding to establish affiliate company in People’s Republic of China
- 2014.02.14
Bringing patent infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the third report)
- 2014.02.04
Notice Regarding Purchase of the Company's Own Shares
- 2014.01.16
Bringing patent/trademark infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the second report)
- 2014.01.16
Notice of Nissan Chemical Group Welfare Fund Activity